|
|
News Breaks | | | | January 16, 2013 | | 08:29 EDT |  | ONXX | Onyx Pharmaceuticals price target lowered to $96 from $99 at RW Baird
Baird lowered its price target on Onyx Pharmaceuticals to reflect the dilutive nature of its secondary offering. The firm has no change to its positive stance and remains buyers of the shares citing bullish signals from its recent Kyprolis survey which is expected to ramp in 2013. Shares are Outperform rated. | |
|
News For ONXX From The Last 14 Days Check below for free stories on ONXX the last two weeks. |
|
|
| June 13, 2013 | | 07:57 EDT |  | ONXX | European Hematology Association to host annual meeting
Annual Meeting of the EHA will be held in Stockholm, Sweden on June 13-16. | |
|
|
|
|
|
|
